Stocks and Investing Stocks and Investing
Wed, January 17, 2024
Tue, January 16, 2024
Mon, January 15, 2024
Fri, January 12, 2024
Thu, January 11, 2024

Shagun Singh Maintained (ABT) at Buy with Increased Target to $128 on, Jan 11th, 2024


Published on 2024-10-28 08:19:07 - WOPRAI, Shagun Singh
  Print publication without navigation


Shagun Singh of RBC Capital, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $119 to $128 on, Jan 11th, 2024.

Shagun has made no other calls on ABT in the last 4 months.



There are 5 other peers that have a rating on ABT. Out of the 5 peers that are also analyzing ABT, 1 agrees with Shagun's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Lewis of "Morgan Stanley" Maintained at Hold with Decreased Target to $107 on, Thursday, October 19th, 2023


These are the ratings of the 4 analyists that currently disagree with Shagun


  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $124 on, Wednesday, January 3rd, 2024
  • Lawrence Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $121 on, Wednesday, December 13th, 2023
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $123 on, Monday, December 11th, 2023
  • Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $133 on, Thursday, October 19th, 2023